XML 77 R52.htm IDEA: XBRL DOCUMENT v3.22.4
Derivative Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2022
Derivative Financial Instruments  
Amounts related to cumulative basis adjustments for fair value hedges

($ in millions)

At December 31:

    

2022

    

2021

Short-term debt

 

  

 

  

Carrying amount of the hedged item

 

$

(199)

 

$

(227)

Cumulative hedging adjustments included in the carrying amount—assets/(liabilities)

1

(2)

Long-term debt

Carrying amount of the hedged item

 

(6,216)

 

(508)

Cumulative hedging adjustments included in the carrying amount—assets/(liabilities)*

72

(309)

* Includes ($250) million and ($302) million of hedging adjustments on discontinued hedging relationships at December 31, 2022 and 2021, respectively.

Effect of derivative instruments in the Consolidated Income Statement

($ in millions)

Gains/(Losses) of

Total

 

Total Hedge Activity

For the year ended December 31:

    

2022

    

2021

2020

2022

    

2021

    

2020

Cost of services

 

$

21,062

$

19,147

$

17,689

$

24

$

43

$

23

Cost of sales

6,374

6,184

6,048

99

(16)

2

Cost of financing

406

534

577

2

1

12

SG&A expense

18,609

18,745

20,561

(211)

176

141

Other (income) and expense

5,803

873

802

(225)

(205)

101

Interest expense

1,216

1,155

1,288

6

3

35

($ in millions)

Gain/(Loss) Recognized in Consolidated Income Statement

Consolidated

Recognized on

Attributable to Risk

Income Statement

Derivatives

Being Hedged (2)

For the year ended December 31:

    

 Line Item

    

2022

    

2021

    

2020

    

2022

    

2021

    

2020

Derivative instruments in fair value hedges (1)

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Interest rate contracts

 

Cost of financing

 

$

(73)

$

(1)

$

20

$

85

$

18

$

4

 

Interest expense

 

(257)

(2)

58

299

53

11

Derivative instruments not designated as hedging instruments

 

Foreign exchange contracts

 

Other (income) and expense

 

(492)

(48)

1

N/A

N/A

N/A

Equity contracts

SG&A expense

(249)

201

142

N/A

N/A

N/A

 

Other (income) and expense

 

(83)

N/A

N/A

N/A

Total

 

  

$

(1,153)

$

150

$

220

$

384

$

71

$

14

($ in millions)

Gain/(Loss) Recognized in Consolidated Income Statement and Other Comprehensive Income

Consolidated

Reclassified

Amounts Excluded from

For the year ended

Recognized in OCI  

Income Statement 

from AOCI  

Effectiveness Testing (3)

December 31:

   

2022

   

2021

   

2020

   

 Line Item

   

2022

   

2021

   

2020

   

2022

   

2021

   

2020

Derivative instruments in cash flow hedges

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Interest rate contracts

 

$

$

$

 

Cost of financing

$

(4)

$

(4)

$

(5)

$

$

$

 

Interest expense

(14)

(13)

(13)

Foreign exchange contracts

241

344

(349)

 

Cost of services

24

43

23

 

Cost of sales

99

(16)

2

 

Cost of financing

(21)

(18)

(23)

 

SG&A expense

38

(24)

0

 

Other (income)
and expense

349

(157)

101

 

Interest expense

(72)

(52)

(65)

Instruments in net investment hedges (4)

 

  

Foreign exchange contracts

1,613

1,644

(2,127)

 

Cost of financing

14

6

16

 

Interest expense

50

17

45

Total

$

1,854

$

1,989

$

(2,477)

 

  

$

400

$

(243)

$

21

$

64

$

23

$

60

(1)

The amount includes changes in clean fair values of the derivative instruments in fair value hedging relationships and the periodic accrual for coupon payments required under these derivative contracts.

(2)

The amount includes basis adjustments to the carrying value of the hedged item recorded during the period and amortization of basis adjustments recorded on de-designated hedging relationships during the period.

(3)

The company’s policy is to recognize all fair value changes in amounts excluded from effectiveness testing in net income each period.

(4)

Instruments in net investment hedges include derivative and non-derivative instruments with the amounts recognized in OCI providing an offset to the translation of foreign subsidiaries.

N/A–Not applicable